KUALA LUMPUR (May 18): Apex Healthcare Bhd's net profit for the first quarter ended March 31, 2022 (1QFY22) surged 32.76% to RM15.77 million, from RM11.88 million a year ago, underpinned by higher sales revenue achieved by its operating subsidiaries.
Meanwhile, Apex Healthcare's quarterly revenue rose 20.3% to RM215.92 million as compared to RM179.49 million in 1QFY21, driven by private sector demand for cough and cold products induced by the Omicron Covid-19 variant — which it said manifested largely as a community respiratory illness.
The group said its improved net profit was also attributed to an improved contribution from its associate company Straits Apex Group Sdn Bhd of RM860,000, a 153.1% increase as compared to a year ago.
"In January and February, production output was again dampened by workforce Covid-19 infections and exacerbated by persistent supply chain disruption for certain components and services. Production output has since improved," it added.
Moving forward, Apex Healthcare said prospects of maintaining recovery are dampened by the repercussions of a protracted war between Ukraine and Russia.
"This is expected to worsen supply disruptions, and add further inflationary pressures to already elevated freight, energy and raw material prices. The risks of slowing global economic growth have risen considerably and the business environment is likely to present greater challenges than in 2021," it added.
However, Apex Healthcare said it will continue to step up its efforts to mitigate such risk, stay focused on its proven fundamentals, as well as be positioned to seize new growth opportunities when presented.
"Further unforeseen market changes and developments aside, the group aims to deliver a satisfactory performance in 2022 amidst the circumstances and remains confident that its longer-term growth prospects remain positive," it added.
Apex Healthcare's share finished nine sen or 3.04% higher at RM3.05 on Wednesday, giving the group a market capitalisation of RM1.45 billion.
- Dalmia Bharat Sugar Q1 net profit jumps over 2-folds to Rs 125.86 crore
- Bharti Infratel Q1 net profit falls 21% on year on weak revenue, higher finance cost
- L&T Q1 net profit falls 79% YoY; order book stands at Rs 3 lakh crore
- Max Ventures' net profit down 47% to Rs 13 crore in Q1 FY21
- Poly Real Estate reports net profit, revenue growth in H1
- Deepak Fertiliser Q1 profit surges to Rs 120 crore on higher IPA sales
- Zee Entertainment posts Q4 net loss at Rs 766 crore
- Dr Reddy's Labs Q1 profit falls 13%; gross margin improves 430 bps YoY
- Hyundai Motor Q2 profit slumps over weak international demand
- Dabur Q1 profit falls 6% to Rs 342 crore, volume declines 9.7%
- UltraTech Cement's profit falls 36% to Rs 806 crore in Q1 FY21
- ACC's profit drops 40.5% to Rs 270.95 crore in Q1 FY21
- Amazon's Q2: $4 billion spent on COVID-19 and still nets $5.2 billion
- Reliance beats Street with record profit in Q1
- Novaland targets VND14.88 trillion in revenue and introducing 8,000 products this year
- HDFC Q1 profit falls 5% YoY to Rs 3,051.5 crore; net interest income jumps 10% YoY
- Masan revenues rise a whopping 103.3 per cent in H1
- Amazon posts biggest profit ever at height of pandemic in U.S.
- NZX closes higher for third consecutive day, after strong run by Mainfreight
- Amgen second-quarter revenue rises 6%, adjusted profit tops Street view
Apex Healthcare 1Q net profit up 33%, carried by higher sales revenue have 514 words, post on www.theedgemarkets.com at May 18, 2022. This is cached page on Business News. If you want remove this page, please contact us.